000 01324 a2200301 4500
005 20250516235102.0
264 0 _c20150710
008 201507s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-14-1371
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDéchanet-Merville, Julie
245 0 0 _aPromising cell-based immunotherapy using gamma delta T cells: together is better.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cNov 2014
300 _a5573-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAnimals
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHumans
650 0 4 _aLymphocyte Activation
_ximmunology
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aNeuroblastoma
_ximmunology
650 0 4 _aReceptors, Antigen, T-Cell, gamma-delta
_xmetabolism
650 0 4 _aT-Cell Antigen Receptor Specificity
_ximmunology
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 20
_gno. 22
_gp. 5573-5
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-14-1371
_zAvailable from publisher's website
999 _c24244154
_d24244154